Asia Pacific Diabetic Foot Ulcer Treatment Market to Grow at a CAGR of 8.5% to reach US$ 1,723.22 Million from 2021 to 2028

The APAC diabetic foot ulcer treatment market is expected to grow from US$ 976.51 million in 2021 to US$ 1,723.22 million by 2028; it is estimated to grow at a CAGR of 8.5% from 2021 to 2028.

China, India, Japan, South Korea, and Australia are major economies in APAC. Rising research activities to introduce novel wound treatment products is expected to escalate the market growth. Chronic wounds such as diabetic foot ulcers often lead to complications, creating a challenge for surgeons to manage such injuries. With the significant increase in patient pool suffering from chronic wounds, the need for a systematic approach for the treatment has increased, which is encouraging the adoption of evidence-based treatment to make wound care effective. Several research and clinical trials related to chronic wounds management have demonstrated that bioactive wound care products improve the healing of moist wounds more effectively than the traditional wound care products. The active participation of government bodies and research organizations is promoting advancements in the wound care treatments. In December 2018, ConvaTec, a wound care specialist, collaborated with Academic Health Science Networks (AHSN) and the National Health Service (NHS) to improve wound care management. So growing research to introduce treatment will drive the market in coming years.

In case of COVID-19, APAC is highly affected specially India.  People are packing India's public hospitals, as many are unable to afford private ones that generally uphold higher standards of care. The outbreak has severely affected the tourism industry and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent disease transmission. All these factors will impact the Diabetic Foot Ulcer Treatment market for a short period of time. The focus on the wound care treatments is less as government and population in the region are more focused on the treatment of COVID 19. The dermatology clinics, hospitals, and surgical centers are open for only emergency services. China is specifically facing issues that this epidemic has caused, leading to disruption of the supply chain, projected decreases in revenue and sales within all industries. As the visits to healthcare settings has declined in response to the pandemic to the regions like South Korea and Japan which has negative impact on the wound care industry. In India, shutdown of the entire transportation within the country, and many provinces are establishing border restrictions within the country. This has led to paralyzed supply chains for any industry in India. However, essential medical product supply is not restricted but the production has been affected due to restriction on number of staff working in the companies. As the vaccination progress, the demand for wound care products is expected to increase which will support the diabetic foot ulcer treatment market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC diabetic foot ulcer treatment market. The APAC diabetic foot ulcer treatment market is expected to grow at a good CAGR during the forecast period.  

APAC Diabetic Foot Ulcer Treatment Market Segmentation       

APAC Diabetic Foot Ulcer Treatment Market – By Type

• Advanced Wound Care Dressings
  • Hydrogel Dressings
  • Collagen Dressing
  • Alginate Dressings
  • Foam Dressings
  • Hydrocolloid Dressings
  • Others
• Biologics
  • Skin Grafts
  • Growth Factors
• Therapy Device
  • Negative Pressure Wound Therapy
  • Ultrasound Therapy

APAC Diabetic Foot Ulcer Treatment Market – By Ulcer Type

• Neuropathic Ulcers
• Ischemic Ulcers
• Neuro-ischemic Ulcers

APAC Diabetic Foot Ulcer Treatment Market – By End User

• Hospitals
• Ambulatory Surgery Centers
• Home Care

APAC Diabetic Foot Ulcer Treatment Market, by Country

• China
• Japan 
• India
• South Korea
• Australia  
• Rest of APAC

APAC Diabetic Foot Ulcer Treatment Market -Companies Mentioned

• 3M
• B. Braun Melsungen AG
• Cardinal Health Inc
• Coloplast Group  
• ConvaTec Group Plc
• Medline Industries, Inc.
• MiMedx
• Mölnlycke Health Care AB.  
• Organogenesis Inc.
• Smith & Nephew
• URGO

Asia Pacific Diabetic Foot Ulcer Treatment Report Scope